Consuelo Treviño-Garza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Consuelo Treviño-Garza has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
- Manuel E. de la O-Cavazos
Servicio de Neonatología del Hospital Universitario "Dr. José Eleuterio González" de la UANL Monterrey, N.L. México
8 shared publications - Fernando Montes-Tapia
Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León
6 shared publications - Roberto Montes-De-Oca-Luna
Histology Department, Faculty of Medicine, Universidad Autonoma de Nuevo Leon (UANL), Monterrey, México
6 shared publications - Ana María Rivas-Estilla
Department of Biochemistry and Molecular Medicine, CIIViM, School of Medicine, Autonomous University of Nuevo Leon, Monterrey, Nuevo León, Mexico
5 shared publications - Daniel Arellanos-Soto
Department of Biochemistry and Molecular Medicine, CIIViM, School of Medicine, Autonomous University of Nuevo Leon, Monterrey, Nuevo León, Mexico
5 shared publications - Javier Ramos-Jiménez
Centro de Investigación e Innovación en Virología Médica, Departamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León
5 shared publications
Latest Publications
- 28 March 2023
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 153 (5)
Vitamin D deficiency in Mexican mothers and their newborns
- 28 March 2023
- Published by Instituto Mexicano del Seguro Social in Gaceta Médica de México
- Vol. 153 (5)
Vitamin D deficiency in Mexican mothers and their newborns
- Open Access
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation
The progression and distribution of the SARS-CoV-2 pandemic are continuously changing over time and can be traced by blood donors’ serological survey. Here, we investigated the seroprevalence of anti-SARS-CoV-2 antibodies in blood donors in Nuevo Leon, Mexico during 2020 as a strategy for the rapid evaluation of the spread of SARS-CoV-2 and asymptomatic case detection. We collected residual plasma samples from blood donors who attended two regional donation centers from January to December of 2020 to identify changes in anti-SARS-CoV-2 IgG prevalence. Plasma samples were analyzed on the Abbott Architect instrument using the commercial Abbott SARS-CoV-2 IgG chemiluminescent assay. We found a total of 99 reactive samples from 2068 analyzed plasma samples, resulting in a raw prevalence of 4.87%. Donors aged 18–49 years were more likely to be seropositive compared to those aged >50 years (p < 0.001). Weekly seroprevalence increased from 1.8% during the early pandemic stage to 27.59% by the end of the year. Prevalence was 1.46-fold higher in females compared to males. Case geographical mapping showed that Monterrey city recorded the majority of SARS-CoV-2 cases. These results show that there is a growing trend of seroprevalence over time associated with asymptomatic infection that is unnoticed under the current epidemiological surveillance protocols.
Open AccessSeroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation
The progression and distribution of the SARS-CoV-2 pandemic are continuously changing over time and can be traced by blood donors’ serological survey. Here, we investigated the seroprevalence of anti-SARS-CoV-2 antibodies in blood donors in Nuevo Leon, Mexico during 2020 as a strategy for the rapid evaluation of the spread of SARS-CoV-2 and asymptomatic case detection. We collected residual plasma samples from blood donors who attended two regional donation centers from January to December of 2020 to identify changes in anti-SARS-CoV-2 IgG prevalence. Plasma samples were analyzed on the Abbott Architect instrument using the commercial Abbott SARS-CoV-2 IgG chemiluminescent assay. We found a total of 99 reactive samples from 2068 analyzed plasma samples, resulting in a raw prevalence of 4.87%. Donors aged 18–49 years were more likely to be seropositive compared to those aged >50 years (p < 0.001). Weekly seroprevalence increased from 1.8% during the early pandemic stage to 27.59% by the end of the year. Prevalence was 1.46-fold higher in females compared to males. Case geographical mapping showed that Monterrey city recorded the majority of SARS-CoV-2 cases. These results show that there is a growing trend of seroprevalence over time associated with asymptomatic infection that is unnoticed under the current epidemiological surveillance protocols.
- Open Access
- 7 June 2021
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (10) , 5873-5879
Prevalence of IgG antibodies induced by the SARS‐COV‐2 virus in asymptomatic adults in Nuevo Leon, Mexico
Population‐based immunoglobulin G (IgG) seroprevalence studies in asymptomatic individuals in Latin America are scarce. The objective of the study was to estimate the prevalence and geographic distribution of IgG antibodies induced by natural SARS‐CoV‐2 infection in asymptomatic adults, 5–8 months after the first case was reported in a northeastern state of Mexico. This was a population‐based cross‐sectional study carried out in Nuevo Leon during August–November 2020. Individuals ≥18 years with no previous diagnosis or symptoms suggestive of COVID‐19 were consecutively screened in one of the busiest subway stations. Also, a search for eligible individuals was done from house‐to‐house, after selecting densely populated geographic sectors of each of the municipalities of the metropolitan area (n = 4495). The IgG antibodies to SARS‐CoV‐2 nucleocapsid protein were analyzed. The IgG antibody positivity rate was 27.1% (95% confidence interval [CI]: 25.8, 28.4); there were no differences by sex or age (p > 0.05). Analysis by month showed a gradual increase from 11.9% (August) to 31.9% (November); Week 39 had the highest positivity rate (42.2%, 95% CI: 34.2, 50.7). Most people did not have evidence of previous SARS‐CoV‐2 infection. Preventive measures and promotion of the COVID‐19 vaccine should be strengthened.
- 7 June 2021
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (10) , 5873-5879
Open AccessPrevalence of IgG antibodies induced by the SARS‐COV‐2 virus in asymptomatic adults in Nuevo Leon, Mexico
Population‐based immunoglobulin G (IgG) seroprevalence studies in asymptomatic individuals in Latin America are scarce. The objective of the study was to estimate the prevalence and geographic distribution of IgG antibodies induced by natural SARS‐CoV‐2 infection in asymptomatic adults, 5–8 months after the first case was reported in a northeastern state of Mexico. This was a population‐based cross‐sectional study carried out in Nuevo Leon during August–November 2020. Individuals ≥18 years with no previous diagnosis or symptoms suggestive of COVID‐19 were consecutively screened in one of the busiest subway stations. Also, a search for eligible individuals was done from house‐to‐house, after selecting densely populated geographic sectors of each of the municipalities of the metropolitan area (n = 4495). The IgG antibodies to SARS‐CoV‐2 nucleocapsid protein were analyzed. The IgG antibody positivity rate was 27.1% (95% confidence interval [CI]: 25.8, 28.4); there were no differences by sex or age (p > 0.05). Analysis by month showed a gradual increase from 11.9% (August) to 31.9% (November); Week 39 had the highest positivity rate (42.2%, 95% CI: 34.2, 50.7). Most people did not have evidence of previous SARS‐CoV‐2 infection. Preventive measures and promotion of the COVID‐19 vaccine should be strengthened.
- Open Access
- 24 May 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-6
Decline in influenza cases in Mexico after the implementation of public health measures for COVID-19
Mexico took swift action and has strictly followed mitigation measures to prevent the spread of coronavirus disease, COVID-19. In this study we compared influenza activity indicators in our country after the implementation of public health measures for COVID-19. We compared indicators of influenza activity in 2020 before and after public health measures were taken to reduce COVID-19 with the corresponding indicators from three preceding years and the immediate one, and the potential decrease in seasonal influenza cases/deaths. Nationwide surveillance data revealed a drastic decline in influenza diagnosis in outpatient clinics and public hospitals, influenza positivity rates of clinical specimens, and confirmed severe cases during the following 10 weeks of 2020 as lockdown activities and control measures were established compared with the same period of 2019. Our results suggest that the measures taken for COVID-19 were effective in reducing the spread of other viral respiratory diseases as influenza in our country.
- 24 May 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-6
Open AccessDecline in influenza cases in Mexico after the implementation of public health measures for COVID-19
Mexico took swift action and has strictly followed mitigation measures to prevent the spread of coronavirus disease, COVID-19. In this study we compared influenza activity indicators in our country after the implementation of public health measures for COVID-19. We compared indicators of influenza activity in 2020 before and after public health measures were taken to reduce COVID-19 with the corresponding indicators from three preceding years and the immediate one, and the potential decrease in seasonal influenza cases/deaths. Nationwide surveillance data revealed a drastic decline in influenza diagnosis in outpatient clinics and public hospitals, influenza positivity rates of clinical specimens, and confirmed severe cases during the following 10 weeks of 2020 as lockdown activities and control measures were established compared with the same period of 2019. Our results suggest that the measures taken for COVID-19 were effective in reducing the spread of other viral respiratory diseases as influenza in our country.
- Open Access
Detection of two CAL.20C SARS-CoV-2 variants in Monterrey metropolitan area in Northeast Mexico
SARS-CoV-2 variants of concern (VOC) are a worldwide problem. CAL.20C is considered a VOC and its distribution should be monitored. We detected two CAL.20C variants in Monterrey, Mexico in patients who had no recent travel history. This indicates that this variant is now transmitted locally in Northeast Mexico.
Open AccessDetection of two CAL.20C SARS-CoV-2 variants in Monterrey metropolitan area in Northeast Mexico
SARS-CoV-2 variants of concern (VOC) are a worldwide problem. CAL.20C is considered a VOC and its distribution should be monitored. We detected two CAL.20C variants in Monterrey, Mexico in patients who had no recent travel history. This indicates that this variant is now transmitted locally in Northeast Mexico.
- Open Access
Seroprevalence of anti-SARS-COV-2 antibodies in blood donors from Nuevo Leon state, Mexico, during the beginning of the COVID-19 pandemic
Summary: Background: The progression and distribution of SARS-CoV-2 is unknown because typically only symptomatic individuals are diagnosed. Aim: We evaluated the seroprevalence of anti-SARS-CoV-2 in blood donors in Nuevo Leon, Mexico as a strategy for asymptomatic case detection of COVID-19 and epidemic progression. Methods/Materials: We tested 1968 blood donors that attended two regional donation centers in Northeast Mexico from January 1 st to August 30, 2020, to identify anti-SARS-CoV-2 IgG by chemiluminescent immunoassay. Additionally, routine tests for donors including Brucella, Chagas, HCV, VDRL, HIV-1, and HBsAg identification were performed. Results: We found 77 donors reactive for anti-SARS-CoV-2 IgG (seroprevalence 3.99%) and none of them had reported recent COVID-19 symptoms. Donors aged 18 to 49 years (89.5%) were more likely to be seropositive compared to those aged 50 years or older (10.5%) (P<0.001). Prevalence of antibodies increased each epidemiological (EPI) week, parallel to the report of confirmed cases by RT-PCR, identifying the highest prevalence between EPI week 33 and 35 (10.2% to 19%). The metropolitan area of Monterrey recorded the highest number of cases. Routine tests showed that the prevalence of anti-Brucella was 0.13%, anti-HCV 0.5%, anti-HIV-1-2 0.14%, HBsAg 0.16%, Chagas 0.48% and syphilis 1.06%. Conclusions: There is a growing trend of seroprevalence over time, parallel to the constantly increasing epidemic curve in our region and it was higher under 49 years of age associated with asymptomatic infection in donors from the Nuevo Leon area. Detection of anti-SARS-CoV-2 in blood donors is a potential tool for tracking the progression and identifying population exposure during the SARS-CoV-2 outbreak.
Open AccessSeroprevalence of anti-SARS-COV-2 antibodies in blood donors from Nuevo Leon state, Mexico, during the beginning of the COVID-19 pandemic
Summary: Background: The progression and distribution of SARS-CoV-2 is unknown because typically only symptomatic individuals are diagnosed. Aim: We evaluated the seroprevalence of anti-SARS-CoV-2 in blood donors in Nuevo Leon, Mexico as a strategy for asymptomatic case detection of COVID-19 and epidemic progression. Methods/Materials: We tested 1968 blood donors that attended two regional donation centers in Northeast Mexico from January 1 st to August 30, 2020, to identify anti-SARS-CoV-2 IgG by chemiluminescent immunoassay. Additionally, routine tests for donors including Brucella, Chagas, HCV, VDRL, HIV-1, and HBsAg identification were performed. Results: We found 77 donors reactive for anti-SARS-CoV-2 IgG (seroprevalence 3.99%) and none of them had reported recent COVID-19 symptoms. Donors aged 18 to 49 years (89.5%) were more likely to be seropositive compared to those aged 50 years or older (10.5%) (P<0.001). Prevalence of antibodies increased each epidemiological (EPI) week, parallel to the report of confirmed cases by RT-PCR, identifying the highest prevalence between EPI week 33 and 35 (10.2% to 19%). The metropolitan area of Monterrey recorded the highest number of cases. Routine tests showed that the prevalence of anti-Brucella was 0.13%, anti-HCV 0.5%, anti-HIV-1-2 0.14%, HBsAg 0.16%, Chagas 0.48% and syphilis 1.06%. Conclusions: There is a growing trend of seroprevalence over time, parallel to the constantly increasing epidemic curve in our region and it was higher under 49 years of age associated with asymptomatic infection in donors from the Nuevo Leon area. Detection of anti-SARS-CoV-2 in blood donors is a potential tool for tracking the progression and identifying population exposure during the SARS-CoV-2 outbreak.
- Open Access
- 24 November 2020
- Published by Springer Nature in Research Square
Decline in influenza cases in Mexico after the implementation of public health measures for COVID-19
Mexico took swift action and has strictly followed mitigation measures to prevent the spread of coronavirus disease, COVID-19. The present study compared indicators of influenza activity in 2020 before and after public health measures were taken to reduce COVID-19 with the corresponding indicators from three preceding years and the immediate one, and the potential decrease in seasonal influenza cases. Nationwide surveillance data revealed a drastic decline in influenza diagnosis in outpatient clinics and public hospitals, positivity rates of clinical specimens, and confirmed severe cases during the following 10 weeks of 2020 as lockdown activities and control measures were established compared with the same period of 2019, suggesting that the measures taken for COVID-19 were effective in reducing the spread of other viral respiratory diseases in our country.
- 24 November 2020
- Published by Springer Nature in Research Square
Open AccessDecline in influenza cases in Mexico after the implementation of public health measures for COVID-19
Mexico took swift action and has strictly followed mitigation measures to prevent the spread of coronavirus disease, COVID-19. The present study compared indicators of influenza activity in 2020 before and after public health measures were taken to reduce COVID-19 with the corresponding indicators from three preceding years and the immediate one, and the potential decrease in seasonal influenza cases. Nationwide surveillance data revealed a drastic decline in influenza diagnosis in outpatient clinics and public hospitals, positivity rates of clinical specimens, and confirmed severe cases during the following 10 weeks of 2020 as lockdown activities and control measures were established compared with the same period of 2019, suggesting that the measures taken for COVID-19 were effective in reducing the spread of other viral respiratory diseases in our country.
- 1 September 2020
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 55 (9) , 1920-1924
Predicting the optimal depth of ultrasound-guided right internal jugular vein central venous catheters in neonates
- 1 September 2020
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 55 (9) , 1920-1924
Predicting the optimal depth of ultrasound-guided right internal jugular vein central venous catheters in neonates
- Open Access
- 3 January 2020
- Published by Instituto Mexicano del Seguro Social in Revista Medicina Universitaria
- Vol. 21 (4)
Analgesic effects of maternal breast milk and sucrose in early, full, and late-term neonates
- 3 January 2020
- Published by Instituto Mexicano del Seguro Social in Revista Medicina Universitaria
- Vol. 21 (4)
Open AccessAnalgesic effects of maternal breast milk and sucrose in early, full, and late-term neonates
- 1 December 2019
- Published by Elsevier in Early Human Development
- Vol. 139, 104842
Differences in omentin-1 levels in term newborns according to birth weight
- 1 December 2019
- Published by Elsevier in Early Human Development
- Vol. 139, 104842
Differences in omentin-1 levels in term newborns according to birth weight